用或不用维护疗法的胸膜切除术对于肌痛性肌痛症患者:一个三中心,现实世界的研究研究
Hao Zhang1, Moli Fan1, Yutong Shi1
1Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China.
Therapeutic advances in neurological disorders
|February 16, 2026
概括
胸膜切除术后的免疫调节药物 (IM) 对肌痛性骨髓灰质炎 (MG) 患者至关重要,改善结果并减少恶化. 对于没有并发症的患者,建议至少进行一年的IM治疗,但没有超过两年的额外益处.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 肌痛性骨髓灰质炎 (MG) 后免疫调节药物 (IM) 的最佳持续时间和必要性尚未得到充分确立.
- 胸膜切除术是MG的关键治疗方法,但其疗效可以通过辅助疗法来提高.
研究的目的:
- 为了确定在MG患者的甲状腺切除术后是否需要IM.
- 通过比较长期临床结果,确定在没有术后恶化的患者中IM的最佳持续时间.
主要方法:
- 一个回顾性,三重中心研究1248个MG患者接受了胸膜切除术.
- 接受IM (n=765) 和不接受IM (n=483) 的患者之间的结局比较.
- 为了验证,进行了倾向分数匹配 (PSM) 和子组分析.
主要成果:
- 接受IM治疗的患者显示出明显更好的结果,包括较低的恶化率 (HR=0.44) 和1年后较高的最小表现状态 (MMS) 率 (OR=2.06).
- 两组之间没有观察到瘤发育或严重并发症的显著差异.
- 在没有术后恶化的患者中,1年以上的IM降低了恶化的风险 (HR=0.67),但延长超过2年的时间没有提供额外的益处.
结论:
- 单独的胸膜切除术不足以在MG患者中获得最佳的结果.
- 胸膜切除术后的IM建议至少持续一年.
- 延长IM超过两年对没有恶化的患者没有额外的好处.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
01:15Myasthenia Gravis: Diagnostic Tests
2.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.7K
01:14Myocarditis III: Medical Management
225
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
225
01:30Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
01:26Atherosclerosis III: Management
459
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
459
01:17Pericarditis III: Medical Management
383
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
383